Satraplatin

Results: 6



#Item
1Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waivers under 18 U.S.C. §208(b)(3) and 21 U.S.C. $355 (n)(4) Otis Brawley, M.D. Commi.ttee:

Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waivers under 18 U.S.C. §208(b)(3) and 21 U.S.C. $355 (n)(4) Otis Brawley, M.D. Commi.ttee:

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2007-07-09 08:23:18
2Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waiver under 21 U.S.C. 355(n)(4) Michael Perry, M.D. Committee: Oncologic Drugs Advisory Committee

Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waiver under 21 U.S.C. 355(n)(4) Michael Perry, M.D. Committee: Oncologic Drugs Advisory Committee

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2007-07-09 08:23:20
3Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and a Waiver under 21 U.S.C. $355 (n)(4) Pamela Haylock, R.N., M.A. Committee:

Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and a Waiver under 21 U.S.C. $355 (n)(4) Pamela Haylock, R.N., M.A. Committee:

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2007-07-09 08:23:20
4Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waiver under 18 U.S .C. §208(b)(3) John T. Farrar, M.D. Committee:

Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waiver under 18 U.S .C. §208(b)(3) John T. Farrar, M.D. Committee:

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2007-07-09 08:23:19
5Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate Shanta Dhara and Stephen J. Lipparda,b,1 aDepartment of Chemistry and bKoch Institute for Integrative Cancer Research, Massachusetts Institute

Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate Shanta Dhara and Stephen J. Lipparda,b,1 aDepartment of Chemistry and bKoch Institute for Integrative Cancer Research, Massachusetts Institute

Add to Reading List

Source URL: www.thedcasite.com

Language: English - Date: 2009-12-14 14:52:58
6

PDF Document

Add to Reading List

Source URL: clincancerres.aacrjournals.org

Language: English